The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 ...
A novel regimen significantly reduced risk for moderate to severe chronic graft-versus-host disease for certain patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback